Expanding Role Seen for Minimal Residual Disease in Managing Multiple Myeloma
The ASCO Post,
Minimal residual disease is a promising biomarker for guiding the management of multiple myeloma that is becoming increasingly…
Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes
Overview of attention for article published in Journal of Internal Medicine, February 2017
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
Good Attention Score compared to outputs of the same age and source (68th percentile)
Readers on
- mendeley
- 171 Mendeley
